Antimicrobial Drugs: Mechanisms, Targets, and Resistance

Antimicrobial Drugs

Definitions: Antibiotic, Synthetic, and Semisynthetic

Antimicrobial drugs are agents used to treat infections by inhibiting or killing microorganisms. Understanding their classification is essential:

• Antibiotic: A substance produced by microorganisms (such as bacteria or fungi) that inhibits or kills other microbes. Example: Penicillin produced by Penicillium fungi.

• Synthetic: Chemically manufactured drugs not derived from natural sources. Example: Sulfonamides.

• Semisynthetic: Modified antibiotics, where the natural molecule is altered chemically to improve efficacy or reduce side effects. Example: Amoxicillin (modified penicillin).

Selective Toxicity

Selective toxicity refers to the ability of an antimicrobial drug to target and harm microbial cells without damaging host cells. This principle is fundamental in drug development, ensuring minimal side effects in patients.

• Drugs exploit differences between microbial and host cell structures (e.g., bacterial cell walls, prokaryotic ribosomes).

• Example: Penicillins target peptidoglycan in bacterial cell walls, absent in human cells.

Characteristics of an Ideal Antimicrobial Drug

An ideal antimicrobial drug should possess the following six characteristics:

• 1. Selective toxicity against the pathogen.

• 2. Effective elimination of the pathogen without harming the host.

• 3. Stability in the body (resists rapid breakdown or excretion).

• 4. Low likelihood of resistance development.

• 5. Minimal side effects and toxicity.

• 6. Reasonable cost and accessibility.

Mechanisms of Antimicrobial Action

Antimicrobial drugs act through six primary mechanisms, each targeting a specific aspect of microbial physiology:

• 1. Inhibition of cell wall synthesis

• 2. Inhibition of protein synthesis (translation)

• 3. Disruption of cytoplasmic membrane

• 4. Inhibition of metabolic pathways

• 5. Inhibition of nucleic acid synthesis

• 6. Inhibition of virus attachment, entry, and uncoating

1. Inhibition of Cell Wall Synthesis

Drugs targeting cell wall synthesis prevent proper formation of peptidoglycan or other wall components, leading to cell lysis.

• Beta-lactams (e.g., penicillins, cephalosporins): Prevent crosslinking of NAM subunits in peptidoglycan, weakening bacterial cell walls.

• Vancomycin: Interferes with alanine bridges linking NAM subunits in Gram-positive bacteria.

• Bacitracin: Blocks transport of NAG and NAM across the cytoplasmic membrane, halting cell wall synthesis.

• Isoniazid and Ethambutol: Disrupt mycolic acid biosynthesis, targeting Mycobacteria (e.g., tuberculosis, leprosy).

• Echinocandins (e.g., caspofungin): Inhibit fungal cell wall synthesis enzymes, causing osmotic rupture.

2. Inhibition of Protein Synthesis (Translation)

These drugs target prokaryotic ribosomes, which differ structurally from eukaryotic ribosomes, allowing selective toxicity.

• 30S Ribosomal Subunit Inhibitors:

  • Aminoglycosides (streptomycin, gentamycin): Change shape of 30S subunit, causing misreading of codons.

  • Tetracyclines: Block tRNA entry into the A-site, preventing amino acid addition.

• 50S Ribosomal Subunit Inhibitors:

  • Chloramphenicol: Blocks enzymatic site, preventing peptide bond formation.

  • Macrolides (erythromycin): Prevent ribosome movement along mRNA.

  • Fomivirsen: Antisense nucleic acid pairs with cytomegalovirus mRNA, blocking translation.

  • Oxazolidinones: Block initiation of transcription; used for drug-resistant Staphylococcus aureus.

• Mupirocin: Inhibits isoleucyl-tRNA synthetase in Staphylococcus and Streptococcus, causing skin infections; does not affect eukaryotic tRNA.

3. Disruption of Cytoplasmic Membrane

Drugs in this category compromise membrane integrity, leading to cell death.

• Gramicidin: Forms channels in bacterial membranes.

• Polyenes (nystatin, amphotericin B): Bind ergosterol, disrupting fungal and some protozoan membranes.

• Azoles (fluconazole) and Allylamines (terbinafine): Inhibit ergosterol synthesis, affecting membrane fluidity.

• Polymyxin: Disrupts bacterial membranes, especially Gram-negatives; used topically due to toxicity.

• Pyrazinamide: Disrupts transport across membranes in Mycobacterium; effective against intracellular, non-replicating cells.

• Praziquantel and Ivermectin: Modify membrane permeability in parasitic worms.

4. Inhibition of Metabolic Pathways

These drugs interfere with essential metabolic reactions unique to pathogens.

• Atovaquone: Disrupts electron transport in protozoa and fungi.

• Sulfonamides: Structural analogs of PABA; inhibit folic acid synthesis, crucial for nucleotide production.

• Amantadine and Rimantadine: Neutralize acidic phagolysosomes, preventing viral uncoating.

5. Inhibition of Nucleic Acid Synthesis

Drugs in this group block DNA or RNA synthesis, preventing replication and transcription.

• Quinolones: Inhibit DNA gyrase, essential for bacterial DNA replication.

• Nucleotide/Nucleoside Analogs: Mimic nucleotides; used as antiviral agents (e.g., acyclovir, AZT).

• Rifampin: Inhibits RNA polymerase.

• Pentamidine and Propamidine Isethionate: Inhibit DNA replication and RNA transcription in protozoans.

• Reverse Transcriptase Inhibitors: (e.g., emtricitabine) used in HIV treatment cocktails.

6. Inhibition of Virus Attachment, Entry, and Uncoating

These agents prevent viruses from binding to or entering host cells, or from uncoating once inside.

• Attachment Agonists: Peptide or sugar analogs block virus binding to cell receptors. Example: Pleconaril blocks attachment of cold viruses, polioviruses, and coxsackievirus.

• Arildone: Prevents removal of poliovirus capsids, interrupting viral replication.

Broad-Spectrum Antibiotics and Superinfections

Definition and Risks

Broad-spectrum antibiotics are effective against a wide range of bacteria, both Gram-positive and Gram-negative. Their use can disrupt normal microbiota, leading to superinfections—opportunistic infections by resistant organisms or fungi.

• Example: Use of broad-spectrum antibiotics may allow Clostridioides difficile to proliferate in the gut, causing severe diarrhea.

Resistance Mechanisms

R Plasmids and Horizontal Gene Transfer

R plasmids are extrachromosomal DNA elements carrying genes for antimicrobial resistance. Bacteria can share R plasmids via horizontal gene transfer methods:

• Conjugation: Direct transfer of plasmids through pilus.

• Transformation: Uptake of free DNA from environment.

• Transduction: Transfer via bacteriophages.

Microbial Resistance Mechanisms

Microorganisms can resist antimicrobial drugs through seven main strategies:

• 1. Enzymatic destruction or inactivation of the drug (e.g., beta-lactamases).

• 2. Alteration of drug target (e.g., changes in ribosomal proteins).

• 3. Decreased permeability or uptake of the drug.

• 4. Increased efflux (pumping out) of the drug.

• 5. Bypass of metabolic pathway inhibited by the drug.

• 6. Overproduction of target to outcompete the drug.

• 7. Formation of biofilms that protect bacteria from drugs.

Multiple Drug Resistance

Multiple drug resistance is defined as resistance to three or more classes of antimicrobial drugs. Pathogens with this trait are especially difficult to treat and require alternative therapies.

Summary Table: Mechanisms of Antimicrobial Action

Mechanism	Drug Examples	Target	Pathogen Type
Cell Wall Synthesis Inhibition	Penicillins, Cephalosporins, Vancomycin, Bacitracin, Isoniazid, Ethambutol, Echinocandins	Peptidoglycan, Mycolic acid, Fungal cell wall	Bacteria, Mycobacteria, Fungi
Protein Synthesis Inhibition	Aminoglycosides, Tetracyclines, Chloramphenicol, Macrolides, Fomivirsen, Oxazolidinones, Mupirocin	30S/50S ribosomal subunits, tRNA synthetase	Bacteria, Viruses (Fomivirsen), Skin pathogens
Cytoplasmic Membrane Disruption	Gramicidin, Polyenes, Azoles, Allylamines, Polymyxin, Pyrazinamide, Praziquantel, Ivermectin	Membrane components (ergosterol, permeability)	Bacteria, Fungi, Protozoa, Worms
Metabolic Pathway Inhibition	Atovaquone, Sulfonamides, Amantadine, Rimantadine	Electron transport, folic acid synthesis, viral uncoating	Protozoa, Fungi, Bacteria, Viruses
Nucleic Acid Synthesis Inhibition	Quinolones, Nucleotide/nucleoside analogs, Rifampin, Pentamidine, Reverse transcriptase inhibitors	DNA gyrase, RNA polymerase, reverse transcriptase	Bacteria, Viruses, Protozoa
Virus Attachment/Entry/Uncoating Inhibition	Pleconaril, Arildone	Viral capsid, cell receptor	Viruses

Key Equations and Concepts

• Drug Efficacy: Often measured by Minimum Inhibitory Concentration (MIC): $\text{MIC} = \text{Lowest concentration of drug that prevents visible growth}$

• Therapeutic Index: Ratio of toxic dose to effective dose: $\text{Therapeutic Index} = \frac{\text{Toxic Dose}}{\text{Effective Dose}}$

Conclusion

Understanding the mechanisms, targets, and resistance strategies of antimicrobial drugs is crucial for effective treatment and prevention of infectious diseases. Awareness of broad-spectrum antibiotics and resistance development guides responsible drug use and informs future research.